Organoclays have been used in drug adsorption processes due being cheap and environmentally friendly materials with a good cost benefit for the water treatment industry. The present work evaluated the adsorption of chlorhexidine, an antimicrobial agent, on the organophilic clay Cloisite 30B by using a 23 fractional factorial design. The main and interactive factors studied were the initial chlorhexidine concentration (0.4 and 0.6 mmol/L), adsorbent mass (0.3 and 0.5 g), and contact time (1 and 6 h). The organophilic clay Cloisite 30B was characterized by XRD and FTIR. To evaluate the impact of pH on the adsorption process, a range from 1 to 13 was used, in increments of one pH unit. The chlorhexidine adsorption parameters used the following adsorption conditions: an initial pH of 6, 200 rpm and a reaction temperature of 25 °C. Kinetic data followed the pseudo-second order model, while equilibrium data fit best to the Sips isotherm, suggesting high affinity and capacity. The maximum removal efficiency reached 95.77%, mainly influenced by the initial chlorhexidine concentration. These findings demonstrate the potential of organoclay for removing pharmaceutical contaminants from water pre-treatment of industrial effluents.
The continuous release of pharmaceutical compounds into aquatic environments poses significant challenges to environmental sustainability, as conventional wastewater treatment plants are often ineffective in removing recalcitrant and bioactive molecules. In this study, the adsorption performance of nanoclay was systematically evaluated for the removal of nystatin, a polyene antifungal of emerging environmental concern, from aqueous solutions. The effects of solution pH, adsorption kinetics, equilibrium isotherms, and adsorption mechanisms were investigated under environmentally relevant conditions. Nanoclay exhibited outstanding removal efficiency, exceeding 98% across a wide pH range (3–11), thereby demonstrating strong operational robustness and minimal sensitivity to pH variations. Structural and spectroscopic analyses (XRD and FTIR) confirmed that adsorption occurred predominantly on the external surface of the nanoclay, without significant disruption of its lamellar structure, and was governed mainly by hydrophobic interactions and hydrogen bonding. Kinetic data were best described by the pseudo-second-order model, with rapid equilibrium achieved within approximately 20 min, indicating high affinity between nystatin and the adsorbent surface. Equilibrium data were best fitted by the Sips isotherm model, reflecting surface heterogeneity and a favorable adsorption process, with a high maximum adsorption capacity of approximately 911 mg/g. A preliminary cost analysis revealed low raw material costs, while energy consumption, particularly during drying, was identified as the main economic limitation. Overall, the results highlight Nanoclay as an efficient, robust, and promising adsorbent for the sustainable removal of hydrophobic pharmaceutical contaminants from water and wastewater.